These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23360921)

  • 1. Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer.
    Reid-Lombardo KM; Fridley BL; Bamlet WR; Cunningham JM; Sarr MG; Petersen GM
    Ann Surg; 2013 Jun; 257(6):1096-102. PubMed ID: 23360921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.
    Dong X; Javle M; Hess KR; Shroff R; Abbruzzese JL; Li D
    Gastroenterology; 2010 Aug; 139(2):464-73, 473.e1-3. PubMed ID: 20416304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
    Wu C; Kraft P; Stolzenberg-Solomon R; Steplowski E; Brotzman M; Xu M; Mudgal P; Amundadottir L; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; Kooperberg C; Petersen GM; Zheng W; Albanes D; Boutron-Ruault MC; Buring JE; Canzian F; Cao G; Duell EJ; Elena JW; Gaziano JM; Giovannucci EL; Hallmans G; Hutchinson A; Hunter DJ; Jenab M; Jiang G; Khaw KT; LaCroix A; Li Z; Mendelsohn JB; Panico S; Patel AV; Qian ZR; Riboli E; Sesso H; Shen H; Shu XO; Tjonneland A; Tobias GS; Trichopoulos D; Virtamo J; Visvanathan K; Wactawski-Wende J; Wang C; Yu K; Zeleniuch-Jacquotte A; Chanock S; Hoover R; Hartge P; Fuchs CS; Lin D; Wolpin BM
    Gut; 2014 Jan; 63(1):152-60. PubMed ID: 23180869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation-related gene variants as risk factors for pancreatic cancer.
    Reid-Lombardo KM; Fridley BL; Bamlet WR; Cunningham JM; Sarr MG; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1251-4. PubMed ID: 21467233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer.
    Dong X; Li Y; Hess KR; Abbruzzese JL; Li D
    Oncologist; 2011; 16(1):61-70. PubMed ID: 21212431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
    Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
    Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
    La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
    Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.
    Zhang L; Wu G; Herrle F; Niedergethmann M; Keese M
    Cancer Genomics Proteomics; 2012; 9(5):287-95. PubMed ID: 22990108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
    Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
    Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals.
    Gentiluomo M; Peduzzi G; Lu Y; Campa D; Canzian F
    Mutagenesis; 2019 Dec; 34(5-6):395-401. PubMed ID: 31748817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.
    Shamai S; Nabiochtchikov I; Kraus S; Zigdon S; Kazanov D; Itzhak-Klutch M; Eizner C; Arber N; Geva R
    PLoS One; 2015; 10(9):e0134469. PubMed ID: 26394139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.
    Biankin AV; Kench JG; Colvin EK; Segara D; Scarlett CJ; Nguyen NQ; Chang DK; Morey AL; Lee CS; Pinese M; Kuo SC; Susanto JM; Cosman PH; Lindeman GJ; Visvader JE; Nguyen TV; Merrett ND; Warusavitarne J; Musgrove EA; Henshall SM; Sutherland RL;
    Gastroenterology; 2009 Aug; 137(2):558-68, 568.e1-11. PubMed ID: 19376121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians.
    Liu Q; Chen J; Mai B; Amos C; Killary AM; Sen S; Wei C; Frazier ML
    Mol Carcinog; 2012 May; 51(5):433-8. PubMed ID: 21656579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.
    Stracquadanio G; Vrugt B; Flury R; Schraml P; Würl P; Müller TH; Knippschild U; Henne-Bruns D; Breitenstein S; Clavien PA; Graf R; Bond GL; Grochola LF
    Clin Cancer Res; 2016 Dec; 22(24):6069-6077. PubMed ID: 27283965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
    Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
    Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.
    Couch FJ; Wang X; Bamlet WR; de Andrade M; Petersen GM; McWilliams RR
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):251-7. PubMed ID: 20056645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma.
    Seeliger H; Pozios I; Assmann G; Zhao Y; Müller MH; Knösel T; Kreis ME; Bruns CJ
    BMC Cancer; 2018 Oct; 18(1):1049. PubMed ID: 30373552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer.
    Sunakawa Y; Stremitzer S; Cao S; Zhang W; Yang D; Wakatsuki T; Ning Y; Yamauchi S; Stintzing S; Sebio A; El-Khoueiry R; Matsusaka S; Parekh A; Barzi A; Azuma M; Watanabe M; Koizumi W; Lenz HJ
    Ann Oncol; 2015 Feb; 26(2):332-9. PubMed ID: 25411415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.